HighRes® and NVIDIA Partner to Advance AI-Driven Autonomous Laboratories
Beverly, MA — January 12, 2026 — HighRes® Biosolutions today announced an expanding collaboration with NVIDIA focused on applying AI to make laboratory automation more reliable, adaptive, and accessible, paving the way toward fully autonomous laboratories.
HighRes and NVIDIA share a vision that AI is the key to unlocking the next generation of lab automation, where systems are no longer brittle or static, but capable of perceiving their environment, adapting in real time, and executing complex workflows with minimal human intervention. NVIDIA brings critical technology building blocks that enable this shift, while HighRes applies them directly to real-world laboratory execution.
At the core of this collaboration is robotic perception, the ability for automated systems to see, understand, and respond to what is happening in the lab. NVIDIA is showcasing these perception-driven capabilities at the J.P. Morgan Healthcare Conference, demonstrating how robots can self-teach, detect potential errors before they occur, and manage variability autonomously. These capabilities are foundational to building truly autonomous labs.
HighRes is extending this perception-driven foundation by pairing it with natural language workflow creation and execution, lowering the barrier to automation for scientists and engineers. Together, perception and natural language orchestration enable labs to move from rigid, hand-coded automation toward flexible systems that translate scientific intent directly into reliable execution.
As part of this work, HighRes is leveraging NVIDIA technologies for both simulation and real-time interaction in the lab, including
- NVIDIA Isaac Sim for digital twins used in laboratory planning,
- NVIDIA Nemotron open model for powering the HighRes CellarioOS lab orchestration platform with reasoning to convert scientific intent into executable automation workflows, and
- Cosmos-Reason1 for object detection, integrated into HighRes’ robotic execution platforms.
“These capabilities represent a meaningful step toward making autonomous labs practical, scalable, and accessible,” said Ira Hoffman, CEO of HighRes Biosolutions. “For years, automation has promised reliability at scale, but only when everything goes exactly as planned. By combining NVIDIA’s AI and simulation technologies with HighRes’ execution layer, we’re enabling systems that can perceive, adapt, and recover, bringing autonomy into everyday laboratory operations.”
HighRes will showcase these AI-enabled automation capabilities live at SLAS2026 in February and will further discuss the collaboration and technical architecture at NVIDIA GTC in March.
About HighRes
HighRes® delivers integrated laboratory automation solutions combining robotics, instrumentation, and intelligent orchestration software. Used by pharma, biotech, and synthetic biology labs worldwide, HighRes' CellarioOS platform enables scientists to design and execute complex workflows through modular automation systems that adapt to evolving research needs. Our technology bridges hardware execution with AI-driven orchestration, advancing the transition from rigid automation to autonomous laboratory operations. Learn more at highresbio.com. Learn more at highresbio.com.
Press Contact
HighRes Biosolutions
Thomas Rawlins, VP, Marketing
+1 (508) 212-4881
trawlins@highresbio.com